View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Capecitabine 1250, Bile Duct Carcinoma, adjuvant
Protocol-ID: 1183 V1.1 (Mini), CAPE1250, Bile Duct Carcinoma adj.Indication(s)
- Bile Duct Carcinoma; ICD-10 C24.-, C24.0, C24.1, C24.8, C24.9
Links
- BILCAP Study Adjuvant capecitabine for biliary tract cancer, ASCO 2017 [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 19.12.2023